Clinical assessment of tetra-sodium 2-methyl-1: 4-naphthohydroquinone diphosphate as a radiosensitiser in the radiotherapy of malignant tumours.
D000818:Animals; D060126:Characidae; D011756:Diphosphates; D009285:Naphthoquinones; D009369:Neoplasms / Q000628:therapy*; D011838:Radiation-Sensitizing Agents; D011878:Radiotherapy; D012964:Sodium; D014812:Vitamin K / Q000031:analogs & derivatives
D011756:Diphosphates; D009285:Naphthoquinones; D011838:Radiation-Sensitizing Agents; D014812:Vitamin K; D012964:Sodium
NEOPLASMS/therapy; RADIOTHERAPY; VITAMIN K/derivatives